Profile: ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

32.98USD
19 Dec 2014
Price Change (% chg)

$0.14 (+0.41%)
Prev Close
$32.85
Open
$32.86
Day's High
$33.49
Day's Low
$32.54
Volume
2,097,764
Avg. Vol
1,191,675
52-wk High
$33.49
52-wk Low
$15.64

Search Stocks

Acadia Healthcare Company, Inc., incorporated on October 24, 2005, is a provider of inpatient behavioral healthcare services in the United States. The Company also provides outpatient behavioral health services to serve the behavioral health and recovery needs of communities throughout the United States. The Company's facilities and services include acute inpatient psychiatric and specialty facilities, residential treatment centers, outpatient community-based services, and other behavioral services.

Acute Inpatient Psychiatric and Specialty Facilities

The Company’s acute inpatient psychiatric facilities provide care in order to stabilize patients that are either a threat to themselves or to others. The acute setting provides 24-hour observation, daily intervention and monitoring by psychiatrists. The Company's facilities, which offer acute care services, provide evaluation and crisis stabilization of patients with severe psychiatric diagnoses through a medical delivery that incorporates structured and intensive medical and behavioral therapies with 24-hour monitoring by a psychiatrist, psychiatric trained nurses, therapists and other direct care staff. As of December 31, 2013, the Company operated 35 facilities that provided acute care/specialty services in addition to other services. The Company’s specialty facilities provide a continuum of care for adults with addictive disorders and co-occurring mental disorders. Its detoxification, inpatient, partial hospitalization and outpatient treatment programs give patients access to the least restrictive level of care.

Residential Treatment Centers

The Company’s residential treatment centers treat patients with behavioral disorders in a non-hospital setting. The facilities balance therapy activities with social, academic and other activities. The Company provides residential treatment care through a medical model residential treatment facility, which offers intensive, medically driven interventions and individualized treatment regimens designed to deal with moderate to high level patient acuity. Treatment is provided by an interdisciplinary team coordinating psychopharmacological, individual, group and family therapy, along with specialized accredited educational programs in both secure and unlocked environments. As of December 31, 2013, the Company operated 16 facilities that provided residential treatment care, in addition to other services.

Outpatient Community-Based Services

The Company's community-based services are provided for two age groups: children and adolescents (seven to 18 years of age) and young children (three months to six years of age). Community-based programs are designed to provide therapeutic treatment to children and adolescents who have a clinically defined emotional, psychiatric or chemical dependency disorder while enabling the youth to remain at home and within their community. Community-based programs developed for these age groups provide an array of therapeutic services to children. As of December 31, 2013, the Company operated five facilities that provided community-based services.

Other Behavioral Services

The Company provides management, administrative and help lines services through contracts with railroads and a call center contract with Wayne County, Michigan. It also provides inpatient contract management services whereby the Company manages behavioral healthcare programs within third-party medical/surgical hospitals.

The Company competes with UHS and Aurora Behavioral Health Care.

Company Address

ACADIA Pharmaceuticals Inc

SUITE 100, 11085 TORREYANA ROAD
SAN DIEGO   CA   92121
P: +1858.5582871
F: +1858.5582872

Search Stocks